The Law Firm of Levi & Korsinsky, LLP Notifies Shareholders of Claims of Breaches of Fiduciary Duty by the Board of Caliper Life Sciences Inc. in Connection With the Sale of Company to PerkinElmer Inc.

NEW YORK, NY--(Marketwire - Sep 12, 2011) - Levi & Korsinsky notifies shareholders of Caliper Life Sciences Inc. ("Caliper" or the "Company") (NASDAQ: CALP) of claims of breaches of fiduciary duty and other violations of state law against the Board of Directors of the Company in connection with the sale of the Company to PerkinElmer Inc. (NYSE: PKI). Under the terms of the transaction, Caliper shareholders will receive $10.50 per share of Caliper stock they own. The transaction has a total value of approximately $600 million. A complaint was filed in Delaware state court.

Click here to learn more about the investigation: http://zlk.9nl.com/CALP, or call: 877-363-5972.

The claims concern whether the Caliper Board of Directors breached their fiduciary duties to Caliper stockholders by failing to adequately shop the Company before entering into this transaction and whether PerkinElmer Inc. is underpaying for Caliper shares, thus unlawfully harming Caliper stockholders.

If you own common stock in Caliper and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/caliper-life-sciences-calp.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.